Research & Discoveries

Immunosuppression Prevalence Doubled, Linked to Medication Use and COVID: Experts

In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. The estimate was 2.7 percent in 2013.
Immunosuppression Prevalence Doubled, Linked to Medication Use and COVID: Experts
UGREEN 3S/Shutterstock
Marina Zhang
|Updated:
0:00

Between 2013 and 2021, rates of immunosuppression in adults doubled, according to estimates from a Journal of the American Medical Association (JAMA) research letter.

In 2021, an estimated 6.6 percent of U.S. adults were immunosuppressed. “This rate of immunosuppression was higher than the previous national estimate of 2.7 percent using the 2013 [National Health Interview Survey],” the authors wrote in their paper.
Marina Zhang
Marina Zhang
Author
Marina Zhang is a health reporter for The Epoch Times. She covers both health news and in-depth features on emerging health issues. Marina holds a bachelor's degree in biomedicine from the University of Melbourne. Contact her at [email protected].
Related Topics